These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4213978)

  • 21. Kinetics of specific in vitro antibody production following influenza immunization.
    Mitchell DM; Fitzharris P; Knight RA; Schild GC
    Clin Exp Immunol; 1982 May; 48(2):491-8. PubMed ID: 7105493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults.
    Fujimoto C; Takeda N; Matsunaga A; Sawada A; Tanaka T; Kimoto T; Shinahara W; Sawabuchi T; Yamaguchi M; Hayama M; Yanagawa H; Yano M; Kido H
    Influenza Other Respir Viruses; 2012 Nov; 6(6):396-403. PubMed ID: 22226319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretory antibodies in respiratory virus infections.
    Petrescu A
    Virologie; 1984; 35(2):133-8. PubMed ID: 6330974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of the hemagglutination inhibition with ether-treated antigen and of the single-radial-haemolysis methods to detect antibody to influenza B viruses.
    Ioniţă E; Creţescu L; Zilişteanu E; Niculescu IT
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):325-30. PubMed ID: 6763512
    [No Abstract]   [Full Text] [Related]  

  • 26. Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus.
    Alford RH; Rossen RD; Butler WT; Kasel JA
    J Immunol; 1967 Apr; 98(4):724-31. PubMed ID: 4164554
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of antigenic and biological properties of influenza B virus strains, isolated in Leningrad in 1955-1967.
    Aleksandrova GI; Goldfarb VE; Garmashova LM; Geft RA; Smorodintsev AA
    Acta Virol; 1971 Nov; 15(6):446-56. PubMed ID: 4400426
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune response of the human respiratory tract. I. Immunoglobulin levels and influenza virus vaccine antibody response.
    Waldman RH; Jurgensen PF; Olsen GN; Ganguly R; Johnson JE
    J Immunol; 1973 Jul; 111(1):38-41. PubMed ID: 4713298
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of receptor destroying enzyme for removing non-specific serum inhibitors against recent influenza virus strains.
    Styk B
    Acta Virol; 1973 Sep; 17(5):446. PubMed ID: 4148123
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of immunity on transmission of influenza: experimental studies.
    Schulman JL
    Prog Med Virol; 1970; 12():128-60. PubMed ID: 4921481
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
    Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody against Hong Kong influenza viruses in pigs.
    Styk B; Sabó A; Blaskovic D; Masárová P; Russ G; Hána L
    Acta Virol; 1971 May; 15(3):211-9. PubMed ID: 4397341
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunity status of the Milanese population towards B-Hong Kong-8-73, the new B type strain and study of the immunizing activity of the old composition vaccine].
    Profeta ML; Zanetti AR; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(5):429-35. PubMed ID: 4788200
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
    Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination.
    Wenzel RP; Hendley JO; Sande MA; Gwaltney JM
    JAMA; 1973 Oct; 226(4):435-8. PubMed ID: 4800234
    [No Abstract]   [Full Text] [Related]  

  • 36. 7S IgM and IgA influenza fluorescent antibodies in serum.
    Brown GC; O'Leary TP
    J Immunol; 1971 Nov; 107(5):1486-8. PubMed ID: 4940624
    [No Abstract]   [Full Text] [Related]  

  • 37. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.
    Walsh EE; Falsey AR
    J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The spreading of influenza virus and its repercussion on the levels of antibodies in man].
    Pérez Breña MP; López Galíndez C; Llacer A; Nájera E; Nájera R
    Bol Oficina Sanit Panam; 1980 Aug; 89(2):113-23. PubMed ID: 6449941
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental infection of pigs with Hong Kong influenza viruses.
    Styk B; Sabó A; Blaskovic D
    Acta Virol; 1971 May; 15(3):221-5. PubMed ID: 4397342
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody response in respiratory secretions of volunteers given live and dead influenza virus.
    Mann JJ; Waldman RH; Togo Y; Heiner GG; Dawkins AT; Kasel JA
    J Immunol; 1968 Apr; 100(4):726-35. PubMed ID: 5645216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.